Advertisement
Advertisement

LUNG

LUNG logo

Pulmonx Corporation Common Stock

2.00
USD
Sponsored
-0.10
-4.52%
Jan 09, 14:33 UTC -5
Open

LUNG Earnings Reports

Positive Surprise Ratio

LUNG beat 20 of 21 last estimates.

95%

Next Report

Date of Next Report
Feb 17, 2026
Estimate for Q4 25 (Revenue/ EPS)
$22.16M
/
-$0.39
Implied change from Q3 25 (Revenue/ EPS)
+3.07%
/
+14.71%
Implied change from Q4 24 (Revenue/ EPS)
-6.74%
/
+18.18%

Pulmonx Corporation Common Stock earnings per share and revenue

On Nov 12, 2025, LUNG reported earnings of -0.34 USD per share (EPS) for Q3 25, beating the estimate of -0.42 USD, resulting in a 20.32% surprise. Revenue reached 21.50 million, compared to an expected 21.29 million, with a 1.02% difference. The market reacted with a -18.88% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analysts forecast an EPS of -0.39 USD, with revenue projected to reach 22.16 million USD, implying an increase of 14.71% EPS, and increase of 3.07% in Revenue from the last quarter.
FAQ
For Q3 2025, Pulmonx Corporation Common Stock reported EPS of -$0.34, beating estimates by 20.32%, and revenue of $21.50M, 1.02% above expectations.
The stock price moved down -18.88%, changed from $1.96 before the earnings release to $1.59 the day after.
The next earning report is scheduled for Feb 17, 2026.
Based on 8 analysts, Pulmonx Corporation Common Stock is expected to report EPS of -$0.39 and revenue of $22.16M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement